Cargando…

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study

INTRODUCTION: Angiosarcomas constitute approximately 2% to 3% of all soft tissue sarcomas, are characterised by an aggressive clinical behaviour and poor outcome. Optimal management of localised angiosarcomas consists of complete surgical resection with or without radiation. However, due to the infi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Constantinidou, Anastasia, Sauve, Nicolas, Stacchiotti, Silvia, Blay, Jean-Yves, Vincenzi, Bruno, Grignani, Giovanni, Rutkowski, Piotr, Guida, Michele, Hindi, Nadia, Klein, Alexander, Thibaud, Valentin, Sufliarsky, Jozef, Desar, Ingrid, Steeghs, Neeltje, Litiere, Saskia, Gelderblom, Hans, Jones, Robin L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451279/ https://www.ncbi.nlm.nih.gov/pubmed/32847839 http://dx.doi.org/10.1136/esmoopen-2020-000787

Ejemplares similares

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

Neoadjuvant Systemic Treatment of Primary Angiosarcoma
por: Heinhuis, Kimberley M., et al.
Publicado: (2020)

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018)

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
por: Mohammadi, Mahmoud, et al.
Publicado: (2023)

Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients
por: Mohammadi, Mahmoud, et al.
Publicado: (2022)

Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies
por: Blay, J.-Y., et al.
Publicado: (2023)

Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
por: Vincenzi, Bruno, et al.
Publicado: (2022)

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
por: Westerdijk, Kim, et al.
Publicado: (2020)

Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2017)

PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study
por: Heinhuis, Kimberley M, et al.
Publicado: (2020)

Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data
por: den Hollander, Dide, et al.
Publicado: (2022)

Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study
por: Dirkson, Anne, et al.
Publicado: (2022)

PARP inhibition in UV-associated angiosarcoma preclinical models
por: Weidema, Marije E., et al.
Publicado: (2021)

Imaging endpoints for clinical trial use: a RECIST perspective
por: Litière, Saskia, et al.
Publicado: (2022)

Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study
por: Verschoor, Arie Jan, et al.
Publicado: (2020)

The BRASS (BReast Angiosarcoma Surveillance Study): Protocol for a retrospective multicentre cohort study to evaluate the management and outcomes of angiosarcoma of the breast and chest wall
por: Banks, Jenny, et al.
Publicado: (2017)

Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma
por: Apice, Gaetano, et al.
Publicado: (2016)

Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups
por: Tomassen, T., et al.
Publicado: (2022)

NEO E-vita—NEO era!
por: Jakob, Heinz, et al.
Publicado: (2022)

Angiosarcoma
por: Jaitley, Shweta
Publicado: (2012)

Gastrointestinal Stromal Tumours (GIST) in Young Adult (18–40 Years) Patients: A Report from the Dutch GIST Registry
por: IJzerman, Nikki S., et al.
Publicado: (2020)

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2009)

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas
por: Weidema, Marije E., et al.
Publicado: (2019)

Angiosarcoma of the scalp
por: DasGupta, Manjiri, et al.
Publicado: (2009)

Cardiac Angiosarcoma
por: Cardoso, Monique Esteves, et al.
Publicado: (2011)

Angiosarcoma of the lung
por: Grafino, Mónica, et al.
Publicado: (2016)

Exuberant angiosarcoma
por: Pontes, Amanda Brilhante, et al.
Publicado: (2017)

Angiosarcoma of the Heart
por: Göbölös, Laszlo, et al.
Publicado: (2021)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Statistical models versus machine learning for competing risks: development and validation of prognostic models
por: Kantidakis, Georgios, et al.
Publicado: (2023)

Assessment of determining factors for severity of NeoCOVIDiabetes in India: A pan India multicentric retrospective study
por: Maheshwari, Anuj, et al.
Publicado: (2023)

Establishment and characterization of the first patient-derived radiation-induced angiosarcoma xenograft model (RT-AS5)
por: Versleijen-Jonkers, Yvonne M. H., et al.
Publicado: (2023)

Neo-Salvarsan
Publicado: (1912)

Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups
por: van Ravensteijn, Stefan G., et al.
Publicado: (2022)

Neoadjuvant pertuzumab in non-metastatic HER2-positive breast tumors: Multicentric study in Peru (NeoHer)
por: Falcon, Silvia, et al.
Publicado: (2022)

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study
por: Verboom, Michiel C., et al.
Publicado: (2017)

cyNeo4j: connecting Neo4j and Cytoscape
por: Summer, Georg, et al.
Publicado: (2015)

Neo-Darwinists and Neo-Aristotelians: how to talk about natural purpose
por: Woodford, Peter
Publicado: (2016)

The land of the past? Neo-populism, neo-fascism, and the failure of the left in Brazil
por: de Souza, Marcelo Lopes
Publicado: (2020)

Cutaneous Angiosarcoma with Metastases
por: Lane, O. G.
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_3gcl3tto0q47rudq166ehr62cg